CK Life Sciences Int'l., (Holdings) Inc.

SEHK:775 Rapporto sulle azioni

Cap. di mercato: HK$3.3b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

CK Life Sciences Int'l. (Holdings) Gestione

Gestione criteri di controllo 2/4

CK Life Sciences Int'l. (Holdings)'s Il CEO è Alan Abel Yu, nominato in Sep2020, e ha un mandato di 3.92 anni. la retribuzione annua totale è HK$ 14.79M, composta da 74.1% di stipendio e 25.9% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.023% delle azioni della società, per un valore di HK$ 764.98K. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 14 anni e 9.4 anni.

Informazioni chiave

Alan Abel Yu

Amministratore delegato

HK$14.8m

Compenso totale

Percentuale dello stipendio del CEO74.1%
Mandato del CEO3.9yrs
Proprietà del CEO0.02%
Durata media del management14yrs
Durata media del Consiglio di amministrazione9.4yrs

Aggiornamenti recenti sulla gestione

Recent updates

There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

May 03
There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

Apr 25
CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Mar 26
CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Sep 27
Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Sep 16
Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

Aug 21
Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

Apr 14
These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

Mar 18
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

Feb 01
If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

Jan 04
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

Dec 09
CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

Nov 18
We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Alan Abel Yu rispetto agli utili di CK Life Sciences Int'l. (Holdings)?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-HK$19m

Mar 31 2024n/an/a

-HK$705k

Dec 31 2023HK$15mHK$11m

HK$17m

Sep 30 2023n/an/a

HK$61m

Jun 30 2023n/an/a

HK$104m

Mar 31 2023n/an/a

HK$118m

Dec 31 2022HK$14mHK$11m

HK$132m

Sep 30 2022n/an/a

HK$130m

Jun 30 2022n/an/a

HK$128m

Mar 31 2022n/an/a

HK$145m

Dec 31 2021HK$14mHK$10m

HK$163m

Sep 30 2021n/an/a

HK$150m

Jun 30 2021n/an/a

HK$138m

Mar 31 2021n/an/a

HK$132m

Dec 31 2020HK$14mHK$11m

HK$125m

Sep 30 2020n/an/a

HK$112m

Jun 30 2020n/an/a

HK$98m

Mar 31 2020n/an/a

HK$140m

Dec 31 2019HK$14mHK$10m

HK$182m

Sep 30 2019n/an/a

HK$223m

Jun 30 2019n/an/a

HK$263m

Mar 31 2019n/an/a

HK$263m

Dec 31 2018HK$13mHK$10m

HK$263m

Sep 30 2018n/an/a

HK$261m

Jun 30 2018n/an/a

HK$259m

Mar 31 2018n/an/a

HK$259m

Dec 31 2017HK$12mHK$9m

HK$258m

Compensazione vs Mercato: La retribuzione totale di Alan Abel ($USD 1.90M ) è superiore alla media delle aziende di dimensioni simili nel mercato Hong Kong ($USD 408.00K ).

Compensazione vs guadagni: La retribuzione di Alan Abel è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Alan Abel Yu (68 yo)

3.9yrs

Mandato

HK$14,788,000

Compensazione

Mr. Ying Choi Yu, also known as Alan Abel, has been the Chief Executive Officer at CK Life Sciences Int'l., (Holdings) Inc. since September 1, 2020 and serves as its Vice President and Executive Director....

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Tzar Kuoi Li
Executive Chairman 22.3yrsHK$125.00k0.023%
HK$ 765.0k
Ying Choi Yu
CEO, VP & Executive Director3.9yrsHK$14.79m0.023%
HK$ 765.0k
Hing Lam Kam
President & Executive Director22.2yrsHK$2.58m0.065%
HK$ 2.1m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 765.0k
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director5.8yrsHK$6.13mNessun dato
Wun Lam Wong
Chief Financial Officerno dataNessun datoNessun dato
Pak To Wu
Chief Operating Officer of Global Operationsno dataNessun datoNessun dato
Yau Wong
Senior Manager of Human Resources & Administrationno dataNessun datoNessun dato
Ching Sze Chiu
General Counselno dataNessun datoNessun dato
Sze Ho
Vice President of Corporate Developmentno dataNessun datoNessun dato
Wai Che Tong Barnes
Chief Corporate Affairs Officerno dataNessun datoNessun dato
Eirene Yeung
Company Secretary22.6yrsNessun datoNessun dato

14.0yrs

Durata media

61yo

Età media

Gestione esperta: Il team dirigenziale di 775 è esperto e expertise (durata media dell'incarico 14 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Tzar Kuoi Li
Executive Chairman 22.3yrsHK$125.00k0.023%
HK$ 765.0k
Ying Choi Yu
CEO, VP & Executive Directorno dataHK$14.79m0.023%
HK$ 765.0k
Hing Lam Kam
President & Executive Directorno dataHK$2.58m0.065%
HK$ 2.1m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 765.0k
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director5.8yrsHK$6.13mNessun dato
Eva Kwok
Independent Non-Executive Director22.2yrsHK$100.00k0.0021%
HK$ 68.0k
Keith Frankel
Co-Chairman of Vitaquest International LLCno dataNessun datoNessun dato
Peter Peace Tulloch
Non-Executive Director22.3yrsHK$75.00k0.011%
HK$ 356.8k
Kai Cheong Kwan
Independent Non-executive Director9.4yrsHK$155.00kNessun dato
Donald Jeffrey Roberts
Independent Non-Executive Director4.1yrsHK$205.00kNessun dato
Joseph Paul Tighe
Independent Non-Executive Director5.2yrsHK$205.00kNessun dato

9.4yrs

Durata media

72yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 775 sono considerati esperti (durata media dell'incarico 9.4 anni).